Sanofi India gains 5%, hits 52-week high; stock soars 8% so far in August

Early this week, the comany's parent firm Sanofi said it will acquire all of the outstanding shares of US-based Principia Biopharma Inc. for a total approximate aggregate equity value of $3.68 billion

Shares of Sanofi India gained 5 per cent and hit fresh 52-week high of Rs 8,835 apiece on the BSE on Friday. At 12:50 pm, the stock was trading at Rs 8,824.5 per share, up 4.8 per cent, on the BSE as against 0.77 per cent rise in the benchmark S&P BSE Sensex. So far in the month of August, the stock has rallied 8.2 per cent on the BSE, as against 1.6 per cent rise in the Sensex, BSE data show.

Early this week, the comany's parent firm Sanofi said it will acquire all of the outstanding shares of US-based